"The good thing about bad news – it sells."
Structural Heart
Do hybrid cars interfere with cardiac implants? Apparently not, study finds
In the 1st study of its kind to examine the interaction between hybrid cars and implantable cardiac devices, researchers found that the electromagnetic waves generated by the green vehicles don’t pose a threat.
"Hybrid cards do not generated clinically relevant amounts of [electromagnetic interference]," according to a team of researchers from the Mayo Clinic of Arizona. "It is safe for patients with ICD to interact with hybrid cars."
Boston Scientific’s Watchman heart implant shows improved safety profile in preliminary results
Boston Scientific (NYSE:BSX) today unveiled new results from a clinical trial of its Watchman stroke prevention device, reporting that the cardiac implant met 2 of 3 co-primary endpoints for safety and effectiveness compared with drug therapy.
Report: Boston Scientific issues alert on its lead-free S-ICD defibrillator
Updated March 8, 2013, 2:30 p.m. with comments from Boston Scientific.
FDA considers patent extension for Edwards’ Sapien TAVI heart implant
Boston Scientific to present full safety results for Watchman heart implant
Boston Scientific (NYSE:BSX) officials changed their mind about an up-coming presentation of study results regarding the company’s Watchman stroke prevention implant, deciding to present the full safety results.
Boston Scientific hesitates to release full safety results for Watchman heart implant
Officials at Boston Scientific (NYSE:BSX) announced this week that they would reveal only limited patient safety results when they present data from a clinical trial of the Watchman stroke prevention implant at the American College of Cardiology conference this week.
Medtronic pays $84M in damages for Edwards TAVI patent infringement
Medtronic lands another EU win for Resolute Integrity stent
UPDATE: FDA warns doc on CoreValve heart implant trial record-keeping issues
Study: Boston Scientific’s Watchman heart implant bests warfarin
The Watchman heart implant made by Boston Scientific (NYSE:BSX) improved quality-of-life measures more than warfarin in atrial fibrillation patients after 1 year, according to a study in the Journal of the American College of Cardiology.